International Stem Cell (ISCO) Initiates Series of Clinical Studies of Human-derived Stem Cells

QualityStocks would like to highlight International Stem Cell Corp. (OTCBB: ISCO). International Stem Cell has developed a process to derive stem cells similar to Embryonic Stem Cells without the need for fertilized embryos and with minimal exposure to non-human cells. These factors provide ISC a unique leadership role in the field of regenerative cell therapy.

In the company’s news yesterday,

International Stem Cell announced it has launched a series of preclinical animal studies of neuronal cells derived from ISCO’s proprietary pluripotent stem cells from unfertilized eggs, with a long-term endpoint of creating a regenerative therapy for Parkinson’s disease (PD).

PD is a disease afflicting the central nervous system, with some symptoms stemming from the loss of dopaminergic neurons in the mid brain.

ISCO’s approach to develop cell-based therapy for the treatment of PD is first to derive neuronal cells successfully from human parthenogenetic stem cells (hpSC). The next step is to evaluate the in vivo safety, functionality and efficacy of hpSCs.

“The ability of neuronal cells to become a specific type of neuron is one of the most important properties that these cells must have to be used in cell-based therapy of neurological disorders. These studies will bring us one step closer to our goal of being able to treat PD,” Dr. Andrey Semechkin, CEO of ISCO stated in the press release.

ISCO uses unfertilized oocytes (eggs) to create hpSC, a method that boasts several advantages over other types of human stem cells. Like human embryonic stem cells (hESCs), hpSCs are pluripotent, which means they carry the ability to become almost any cell type in the body.

Where hpSCs differ from hESCs is in their ability to become a cell form that can be immunologically matched to millions of individuals, creating deeper potential for regenerative therapy.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.